Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Biomarkers in liver disease: emerging methods and potential applications.

Aithal GP, Guha N, Fallowfield J, Castera L, Jackson AP.

Int J Hepatol. 2012;2012:437508. doi: 10.1155/2012/437508. Epub 2012 Nov 7. No abstract available.

2.

Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers.

Gowda GA.

Biomark Med. 2010 Apr;4(2):299-314. doi: 10.2217/bmm.10.6. Review.

PMID:
20406071
3.

Using biomarkers in sewage to monitor community-wide human health: isoprostanes as conceptual prototype.

Daughton CG.

Sci Total Environ. 2012 May 1;424:16-38. doi: 10.1016/j.scitotenv.2012.02.038. Epub 2012 Mar 15. Review.

4.

Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

Gressner OA, Weiskirchen R, Gressner AM.

Clin Chim Acta. 2007 Jun;381(2):107-13. Epub 2007 Feb 27. Review.

PMID:
17399697
5.

Emerging applications of kinetic biomarkers in preclinical and clinical drug development.

Turner SM, Hellerstein MK.

Curr Opin Drug Discov Devel. 2005 Jan;8(1):115-26. Review.

PMID:
15679179
6.

Circulating markers of liver fibrosis progression.

Jarcuska P, Janicko M, Veselíny E, Jarcuska P, Skladaný L.

Clin Chim Acta. 2010 Aug 5;411(15-16):1009-17. doi: 10.1016/j.cca.2010.04.009. Epub 2010 Apr 23. Review.

PMID:
20399764
7.

Emerging roles for biomaterials in the treatment of liver disease.

Hammond JS, Lobo DN.

Expert Rev Med Devices. 2012 Mar;9(2):181-8. doi: 10.1586/erd.11.70. Review.

PMID:
22404778
8.

Biomarkers--a pot of gold or a can of worms?: Meeting report from the 2nd World Congress on Biomarkers & Clinical Research, 2011, Baltimore, USA.

Weber GF, Warren J, Shoma H, Chen T, Halim A, Chakravarty G.

Cancer Biol Ther. 2012 Aug;13(10):831-5. doi: 10.4161/cbt.20847. Epub 2012 Aug 1.

PMID:
22785203
9.
10.

Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?

Konstantino Y, Wolk R, Terra SG, Nguyen TT, Fryburg DA.

Acute Card Care. 2007;9(4):197-206. Review.

PMID:
17924231
11.

Noninvasive tools to assess liver disease.

Patel K.

Curr Opin Gastroenterol. 2010 May;26(3):227-33. doi: 10.1097/MOG.0b013e3283383c68. Review.

PMID:
20179592
12.

Novel diagnostic and prognostic modalities in inflammatory bowel disease.

Zisman TL, Rubin DT.

Med Clin North Am. 2010 Jan;94(1):155-78. doi: 10.1016/j.mcna.2009.10.003.

PMID:
19944803
13.

Biomarkers of liver fibrosis.

Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V.

Adv Clin Chem. 2008;46:131-60. Review.

PMID:
19004189
14.

Differential diagnosis of liver diseases using serum biomarkers.

Cujic D, Golubovic S, Bojic-Trbojevic Z, Ilic N, Baricevic I, Nedic O.

J BUON. 2010 Jan-Mar;15(1):141-6.

PMID:
20414942
15.

Review of fecal biomarkers in inflammatory bowel disease.

Sutherland AD, Gearry RB, Frizelle FA.

Dis Colon Rectum. 2008 Aug;51(8):1283-91. doi: 10.1007/s10350-008-9310-8. Epub 2008 Jun 10. Review.

PMID:
18543035
16.

Quantum dots: emerging applications in urologic oncology.

Shi C, Zhu Y, Cerwinka WH, Zhau HE, Marshall FF, Simons JW, Nie S, Chung LW.

Urol Oncol. 2008 Jan-Feb;26(1):86-92. doi: 10.1016/j.urolonc.2007.03.018. Review.

PMID:
18190836
17.

Role of biomarkers in studies of presymptomatic Alzheimer's disease.

Morris JC, Kimberly A, Quaid K, Holtzman DM, Kantarci K, Kaye J, Reiman EM, Klunk WE, Siemers ER.

Alzheimers Dement. 2005 Oct;1(2):145-51. doi: 10.1016/j.jalz.2005.09.013.

PMID:
19595847
18.

Applications of 'decisionable' biomarkers in cardiovascular drug development.

Krishna R, Wagner JA.

Biomark Med. 2010 Dec;4(6):815-27. doi: 10.2217/bmm.10.107. Review.

PMID:
21133701
19.

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.

Maor Y, Calès P, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P.

Haemophilia. 2007 Nov;13(6):722-9.

PMID:
17973848
20.

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.

Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A.

Aliment Pharmacol Ther. 2011 Nov;34(10):1202-16. doi: 10.1111/j.1365-2036.2011.04861.x. Epub 2011 Oct 9.

Supplemental Content

Support Center